Vaccine design could dramatically improve cancer immunotherapies: study

          Source: Xinhua| 2019-05-09 06:39:30|Editor: yan
          Video PlayerClose

          CHICAGO, May 8 (Xinhua) -- After comparing a series of compositionally identical yet structurally different vaccines by testing them on multiple animal models, researchers at Northwestern University found the structure of spherical nucleic acids (SNAs) in one vaccine dramatically outperformed others in stimulating cancer-quelling immune responses.

          In the study, the researchers compared SNAs that have different structures but the same peptides, DNA and other general components. All vaccines included an antigen, a substance that is recognized and targeted by an immune response; and an adjuvant, a substance that enhances the body's immune response to the antigen. In this case, the DNA is the adjuvant, and the peptide is the antigen.

          The only thing that changed in each vaccine was the position of the peptide antigen, which was either housed in the core of the SNA, interspersed with the DNA or attached to the DNA. These changes led to major differences in how the immune system recognized and processed molecular cues, which ultimately affects the quality of the immune response generated by the vaccine.

          In the study, the peptide antigen interspersed with the DNA performed best.

          "The study shows that SNAs and our ability to refine SNA structures can dramatically improve the anti-tumor immune responses," said Bin Zhang, professor of medicine and microbiology-immunology at the Northwestern University Feinberg School of Medicine. "This shows promise in our ability to improve the performance of vaccines and eventually use them in patient care."

          Vaccines with the superior structure completely eliminated tumors in 30 percent of animals and improved their overall survival from cancer. The vaccine also protected the animals from reemerging tumors.

          The development of SNAs could be the breakthrough. SNAs are synthetic globular, rather than linear, forms of DNA and RNA that surround a nanoparticle core. Roughly 50 nanometers in diameter, the tiny structures possess the ability to enter cells, including immune cells, for targeted treatment delivery.

          The study, posted on NU website on Monday, is scheduled to be published online in the Proceedings of the National Academy of Sciences this week.

          TOP STORIES
          EDITOR’S CHOICE
          MOST VIEWED
          EXPLORE XINHUANET
          010020070750000000000000011105521380441091
          无码人妻一区二区三区四区av_亚洲精品911在线永久观看_精品一区二区国产在线观看_日韩不卡一区二区视频在线

                  色色色导航一区二区三区 | 一本久久伊人热热精品中文 | 色色色色五月天亚洲 | 亚洲Aⅴ午夜福利精品一区 一本精品99久久精品77 | 亚洲欧洲国产精品片. | 午夜A级理论片在线播放 |